Advertisement

Journal of Neural Transmission

, Volume 115, Issue 4, pp 585–591 | Cite as

Botulinum toxin in the treatment of blepharospasm and hemifacial spasm

  • C. KenneyEmail author
  • J. Jankovic
Article

Summary

Blepharospasm and hemifacial spasm are the two most common craniofacial movement disorders. Blepharospasm is a syndrome characterized by excessive or continuous eye closure related to overactivity of the orbicularis oculi and adjacent muscles bilaterally. Hemifacial spasm is a peripherally-induced movement disorder typically caused by vascular compression of cranial nerve VII (CN VII) leading to involuntary unilateral contractions of muscles used in facial expression. Treatment options for both conditions include medications, botulinum toxin, and various surgical interventions. This article summarizes the existing medical literature which indicates that botulinum toxin is the treatment of choice for blepharospasm and hemifacial spasm.

Keywords: Botulinum toxin; blepharospasm; hemifacial spasm 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Albanese, A, Bentivoglio, AR, Colosimo, C, Galardi, G, Maderna, L, Tonali, P 1996Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patientsJ Neurol Neurosurg Psychiatry60693694PubMedGoogle Scholar
  2. Astarloa, R, Morales, B, Sanchez, V, Penafiel, N, Rabano, J, Olivan, J, Garcia de Yebenes, J 1991Focal dystonias and facial hemispasm: treatment with botulinum A toxinArch Neurobiol (Madr)54210217Google Scholar
  3. Auger, RG, Piepgras, DG, Laws, ER,Jr 1986Hemifacial spasm: results of microvascular decompression of the facial nerve in 54 patientsMayo Clin Proc61640644PubMedGoogle Scholar
  4. Auger, RG, Whisnant, JP 1990Hemifacial spasm in Rochester and Olmsted County, Minnesota, 1960 to 1984Arch Neurol4712331234PubMedGoogle Scholar
  5. Ben Simon, GJ, McCann, JD 2005Benign essential blepharospasmInt Ophthalmol Clin454975PubMedCrossRefGoogle Scholar
  6. Berardelli, A, Carta, A, Stocchi, F, Formica, A, Agnoli, A, Manfredi, M 1990Botulinum A toxin injection in patients with blepharospasm, torticollis and hemifacial spasmItal J Neurol Sci11589593PubMedCrossRefGoogle Scholar
  7. Cakmur, R, Ozturk, V, Uzunel, F, Donmez, B, Idiman, F 2002Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasmJ Neurol2496468PubMedCrossRefGoogle Scholar
  8. Cossu, G, Mereu, A, Deriu, M, Melis, M, Molari, A, Melis, G, Minafra, L, Pisano, T, Cianchetti, C, Ortu, E, Sau, G, Aiello, I, Fresu, M, Marrosu, MG, Contu, P 2006Prevalence of primary blepharospasm in Sardinia, Italy: a service-based surveyMov Disord2120052008PubMedCrossRefGoogle Scholar
  9. Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005a) Botulinum toxin type A therapy for blepharospasm. Cochrane Database Syst Rev: CD004900Google Scholar
  10. Costa J, Espirito-Santo C, Borges A, Ferreira JJ, Coelho M, Moore P, Sampaio C (2005b) Botulinum toxin type A therapy for hemifacial spasm. Cochrane Database Syst Rev: CD004899Google Scholar
  11. Dutton, JJ, White, JJ, Richard, MJ 2006Myobloc for the treatment of benign essential blepharospasm in patients refractory to botoxOphthal Plast Reconstr Surg22173177PubMedCrossRefGoogle Scholar
  12. Elston, JS 1986Botulinum toxin treatment of hemifacial spasmJ Neurol Neurosurg Psychiatry49827829PubMedGoogle Scholar
  13. Fahn, S, List, T, Moslowitz, C, Brin, M, Bressman, SB, Burke, RE, Scott, A 1985Double-blind controlled study of botulinum toxin for blepharospasmNeurology35271272Google Scholar
  14. Frueh, BR, Nelson, CC, Kapustiak, JF, Musch, DC 1988The effect of omitting botulinum toxin from the lower eyelid in blepharospasm treatmentAm J Ophthalmol1064547PubMedCrossRefGoogle Scholar
  15. Galvez-Jimenez, N, Hanson, MR, Desai, M 2001Unusual causes of hemifacial spasmSemin Neurol217583PubMedCrossRefGoogle Scholar
  16. Grandas, F, Elston, J, Quinn, N, Marsden, CD 1988Blepharospasm: a review of 264 patientsJ Neurol Neurosurg Psychiatry51767772PubMedGoogle Scholar
  17. Iwashige, H, Nemeto, Y, Takahashi, H, Maruo, T 1995Botulinum toxin type A purified neurotoxin complex for the treatment of blepharospasm: a dose-response study measuring eyelid forceJpn J Ophthalmol39424431PubMedGoogle Scholar
  18. Jankovic, J 1995Apraxia of lid openingMov Disord10686687PubMedGoogle Scholar
  19. Jankovic, J 1996Pretarsal injection of botulinum toxin for blepharospasm and apraxia of eyelid openingJ Neurol Neurosurg Psychiatry60704PubMedCrossRefGoogle Scholar
  20. Jankovic, J, Orman, J 1987Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled studyNeurology37616623PubMedGoogle Scholar
  21. Jankovic, J, Schwartz, K, Donovan, DT 1990Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasmJ Neurol Neurosurg Psychiatry53633639PubMedGoogle Scholar
  22. Jankovic, J, Vuong, KD, Ahsan, J 2003Comparison of efficacy and immunogenicity of original versus current botulinum toxin in cervical dystoniaNeurology6011861188PubMedGoogle Scholar
  23. Jitpimolmard, S, Tiamkao, S, Laopaiboon, M 1998Long term results of botulinum toxin type A (Dysport) in the treatment of hemifacial spasm: a report of 175 casesJ Neurol Neurosurg Psychiatry64751757PubMedGoogle Scholar
  24. Jost, WH, Kohl, A 2001Botulinum toxin: evidence-based medicine criteria in blepharospasm and hemifacial spasmJ Neurol2482124PubMedCrossRefGoogle Scholar
  25. Kowal, L 1997Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patientsJ Neurol Neurosurg Psychiatry63556PubMedGoogle Scholar
  26. Levy, RL, Berman, D, Parikh, M, Miller, NR 2006Supramaximal doses of botulinum toxin for refractory blepharospasmOphthalmology11316651668PubMedCrossRefGoogle Scholar
  27. Loeser, JD, Chen, J 1983Hemifacial spasm: treatment by microsurgical facial nerve decompressionNeurosurgery13141146PubMedCrossRefGoogle Scholar
  28. MacAndie, K, Kemp, E 2004Impact on quality of life of botulinum toxin treatments for essential blepharospasmOrbit23207210PubMedCrossRefGoogle Scholar
  29. Mauriello, JA,Jr, Keswani, R, Franklin, M 1999Long-term enhancement of botulinum toxin injections by upper-eyelid surgery in 14 patients with facial dyskinesiasArch Otolaryngol Head Neck Surg125627631PubMedGoogle Scholar
  30. Micheli, F, Scorticati, MC, Gatto, E, Cersosimo, G, Adi, J 1994Familial hemifacial spasmMov Disord9330332PubMedCrossRefGoogle Scholar
  31. Novis, SA, De Mattos, JP, De Rosso, AL 1995Botulinum toxin in blepharospasm, in hemifacial spasm, and in cervical dystonia: results in 33 patientsArq Neuropsiquiatr53403410PubMedGoogle Scholar
  32. Nutt, JG, Muenter, MD, Aronson, A, Kurland, LT, Melton, LJ,3rd 1988Epidemiology of focal and generalized dystonia in Rochester, MinnesotaMov Disord3188194PubMedCrossRefGoogle Scholar
  33. Pang, AL, O’Day, J 2006Use of high-dose botulinum A toxin in benign essential blepharospasm: is too high too much?Clin Experiment Ophthalmol34441444PubMedCrossRefGoogle Scholar
  34. Park, YC, Lim, JK, Lee, DK, Yi, SD 1993Botulinum a toxin treatment of hemifacial spasm and blepharospasmJ Korean Med Sci8334340PubMedGoogle Scholar
  35. Piatt, JH,Jr, Wilkins, RH 1984Treatment of tic douloureux and hemifacial spasm by posterior fossa exploration: therapeutic implications of various neurovascular relationshipsNeurosurgery14462471PubMedCrossRefGoogle Scholar
  36. Reimer, J, Gilg, K, Karow, A, Esser, J, Franke, GH 2005Health-related quality of life in blepharospasm or hemifacial spasmActa Neurol Scand1116470PubMedCrossRefGoogle Scholar
  37. Rieder, CR, Schestatsky, P, Socal, MP, Monte, TL, Fricke, D, Costa, J, Picon, PD 2007A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasmClin Neuropharmacol303942PubMedCrossRefGoogle Scholar
  38. Roggenkamper, P, Jost, WH, Bihari, K, Comes, G, Grafe, S 2006Efficacy and safety of a new Botulinum Toxin Type A free of complexing proteins in the treatment of blepharospasmJ Neural Transm113303312PubMedCrossRefGoogle Scholar
  39. Sampaio, C, Ferreira, JJ, Simoes, F, Rosas, MJ, Magalhaes, M, Correia, AP, Bastos-Lima, A, Martins, R, Castro-Caldas, A 1997DYSBOT: a single-blind, randomized parallel study to determine whether any differences can be detected in the efficacy and tolerability of two formulations of botulinum toxin type A – Dysport and Botox-assuming a ratio of 4:1Mov Disord1210131018PubMedCrossRefGoogle Scholar
  40. Sandberg, DI, Souweidane, MM 1999Hemifacial spasm caused by a pilocytic astrocytoma of the fourth ventriclePediatr Neurol21754756PubMedCrossRefGoogle Scholar
  41. Schnider, P, Birner, P, Moraru, E, Auff, E 1999Long-term treatment with botulinum toxin: dosage, treatment schedules and costsWien Klin Wochenschr1115965PubMedGoogle Scholar
  42. Scott, AB, Kennedy, RA, Stubbs, HA 1985Botulinum A toxin injection as a treatment for blepharospasmArch Ophthalmol103347350PubMedGoogle Scholar
  43. Tan, EK, Chan, LL, Lim, SH, Lim, WE, Khoo, JB, Tan, KP 1999Role of magnetic resonance imaging and magnetic resonance angiography in patients with hemifacial spasmAnn Acad Med Singapore28169173PubMedGoogle Scholar
  44. Tan, EK, Fook-Chong, S, Lum, SY, Lim, E 2004Botulinum toxin improves quality of life in hemifacial spasm: validation of a questionnaire (HFS-30)J Neurol Sci219151155PubMedCrossRefGoogle Scholar
  45. Tan, EK, Jankovic, J 1999Bilateral hemifacial spasm: a report of five cases and a literature reviewMov Disord14345349PubMedCrossRefGoogle Scholar
  46. Tan, NC, Chan, LL, Tan, EK 2002Hemifacial spasm and involuntary facial movementsQJM95493500PubMedCrossRefGoogle Scholar
  47. Truong, DD, Jost, WH 2006Botulinum toxin: clinical useParkinsonism Relat Disord12331355PubMedCrossRefGoogle Scholar
  48. Tucha, O, Naumann, M, Berg, D, Alders, GL, Lange, KW 2001Quality of life in patients with blepharospasmActa Neurol Scand1034952PubMedCrossRefGoogle Scholar
  49. Urban, PP 2006Pregabalin as add-on treatment to botulinum toxin in idiopathic hemifacial spasmNeurology661781PubMedCrossRefGoogle Scholar
  50. Wang, A, Jankovic, J 1998Hemifacial spasm: clinical findings and treatmentMuscle Nerve2117401747PubMedCrossRefGoogle Scholar
  51. Yoshimura, DM, Aminoff, MJ, Tami, TA, Scott, AB 1992Treatment of hemifacial spasm with botulinum toxinMuscle Nerve1510451049PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Parkinson’s Disease Center and Movement Disorders Clinic, Department of NeurologyBaylor College of MedicineHoustonU.S.A.

Personalised recommendations